Part II drafted from the short text of the French guidelines entitled “Initial management of patients with epithelial ovarian cancer” developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment, elderly, fertility preservation, follow-up)

V. Lavoué; C. Huchon; C. Akladios; P. Alfonsi; N. Bakrin; M. Ballester; S. Bendifallah; P. A. Bolze; F. Bonnet; C. Bourgin; N. Chabbert-Buffet; P. Collinet; B. Courbiere; T. De la Motte Rouge; M. Devouassoux-Shisheboran; C. Falandry; G. Ferron; L. Fournier; L. Gladieff; F. Golfier; S. Gouy; F. Guyon; E. Lambaudie; A. Leary; F. Lécuru; M. A. Lefrère-Belda; E. Leblanc; A. Lemoine; F. Narducci; L. Ouldamer; P. Pautier; F. Planchamp; N. Pouget; I. Ray-Coquard; C. Rousset-Jablonski; C. Sénéchal-Davin; C. Touboul; I. Thomassin-Naggara; C. Uzan; B. You; E. Daraï

doi:10.1016/j.gofs.2018.12.011

Part II drafted from the short text of the French guidelines entitled “Initial management of patients with epithelial ovarian cancer” developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment, elderly, fertility preservation, follow-up)

Titre traduit de la contribution: Partie 2 rédigée à partir de la synthèse de la recommandation nationale de bonnes pratiques cliniques intitulée « Conduites à tenir initiales devant des patientes atteintes d'un cancer épithélial de l'ovaire » élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY et labélisée par l'INCa. (Traitement systémique et intrapéritonéal, personnes âgées, préservation de la fertilité et suivi)

V. Lavoué, C. Huchon, C. Akladios, P. Alfonsi, N. Bakrin, M. Ballester, S. Bendifallah, P. A. Bolze, F. Bonnet, C. Bourgin, N. Chabbert-Buffet, P. Collinet, B. Courbiere, T. De la Motte Rouge, M. Devouassoux-Shisheboran, C. Falandry, G. Ferron, L. Fournier, L. Gladieff, F. GolfierS. Gouy, F. Guyon, E. Lambaudie, A. Leary, F. Lécuru, M. A. Lefrère-Belda, E. Leblanc, A. Lemoine, F. Narducci, L. Ouldamer, P. Pautier, F. Planchamp, N. Pouget, I. Ray-Coquard, C. Rousset-Jablonski, C. Sénéchal-Davin, C. Touboul, I. Thomassin-Naggara, C. Uzan, B. You, E. Daraï

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

4 Citations (Scopus)

Résumé

Adjuvant chemotherapy with carboplatin and paclitaxel is recommended for all high-grade ovarian or Fallopian tube cancers, stage FIGO I-IIA (grade A). After a complete first surgery, it is recommended to deliver 6 cycles of intravenous (grade A) or to propose intraperitoneal (grade B) chemotherapy, to be discussed with patient, according to the benefit/risk ratio. After a complete interval surgery for a FIGO III stage, the hyperthermic intra peritoneal chemotherapy (HIPEC) can be proposed in the same conditions of the OV-HIPEC trial (grade B). In case of tumor residue after surgery or FIGO stage IV, chemotherapy associated with bevacizumab is recommended (grade A). For BRCA mutated patient, Olaparib is recommended (grade B).

Titre traduit de la contribution	Partie 2 rédigée à partir de la synthèse de la recommandation nationale de bonnes pratiques cliniques intitulée « Conduites à tenir initiales devant des patientes atteintes d'un cancer épithélial de l'ovaire » élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY et labélisée par l'INCa. (Traitement systémique et intrapéritonéal, personnes âgées, préservation de la fertilité et suivi)
langue originale	Anglais
Pages (de - à)	111-119
Nombre de pages	9
journal	Gynecologie Obstetrique Fertilite et Senologie
Volume	47
Numéro de publication	2
Les DOIs	https://doi.org/10.1016/j.gofs.2018.12.011
état	Publié - 1 févr. 2019

Accès au document

10.1016/j.gofs.2018.12.011

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Lavoué, V., Huchon, C., Akladios, C., Alfonsi, P., Bakrin, N., Ballester, M., Bendifallah, S., Bolze, P. A., Bonnet, F., Bourgin, C., Chabbert-Buffet, N., Collinet, P., Courbiere, B., De la Motte Rouge, T., Devouassoux-Shisheboran, M., Falandry, C., Ferron, G., Fournier, L., Gladieff, L., ... Daraï, E. (2019). Part II drafted from the short text of the French guidelines entitled “Initial management of patients with epithelial ovarian cancer” developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment, elderly, fertility preservation, follow-up). Gynecologie Obstetrique Fertilite et Senologie, 47(2), 111-119. https://doi.org/10.1016/j.gofs.2018.12.011

Lavoué, V. ; Huchon, C. ; Akladios, C. et al. / Part II drafted from the short text of the French guidelines entitled “Initial management of patients with epithelial ovarian cancer” developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment, elderly, fertility preservation, follow-up). Dans: Gynecologie Obstetrique Fertilite et Senologie. 2019 ; Vol 47, Numéro 2. p. 111-119.

@article{850d250abdba423b97c11590ef5d056f,

title = "Part II drafted from the short text of the French guidelines entitled “Initial management of patients with epithelial ovarian cancer” developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment, elderly, fertility preservation, follow-up)",

abstract = "Adjuvant chemotherapy with carboplatin and paclitaxel is recommended for all high-grade ovarian or Fallopian tube cancers, stage FIGO I-IIA (grade A). After a complete first surgery, it is recommended to deliver 6 cycles of intravenous (grade A) or to propose intraperitoneal (grade B) chemotherapy, to be discussed with patient, according to the benefit/risk ratio. After a complete interval surgery for a FIGO III stage, the hyperthermic intra peritoneal chemotherapy (HIPEC) can be proposed in the same conditions of the OV-HIPEC trial (grade B). In case of tumor residue after surgery or FIGO stage IV, chemotherapy associated with bevacizumab is recommended (grade A). For BRCA mutated patient, Olaparib is recommended (grade B).",

keywords = "Chemotherapy, Fallopian tube cancer, Guidelines, Ovarian cancer, Peritoneal cancer, Surgery",

author = "V. Lavou{\'e} and C. Huchon and C. Akladios and P. Alfonsi and N. Bakrin and M. Ballester and S. Bendifallah and Bolze, {P. A.} and F. Bonnet and C. Bourgin and N. Chabbert-Buffet and P. Collinet and B. Courbiere and {De la Motte Rouge}, T. and M. Devouassoux-Shisheboran and C. Falandry and G. Ferron and L. Fournier and L. Gladieff and F. Golfier and S. Gouy and F. Guyon and E. Lambaudie and A. Leary and F. L{\'e}curu and Lefr{\`e}re-Belda, {M. A.} and E. Leblanc and A. Lemoine and F. Narducci and L. Ouldamer and P. Pautier and F. Planchamp and N. Pouget and I. Ray-Coquard and C. Rousset-Jablonski and C. S{\'e}n{\'e}chal-Davin and C. Touboul and I. Thomassin-Naggara and C. Uzan and B. You and E. Dara{\"i}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Masson SAS",

year = "2019",

month = feb,

day = "1",

doi = "10.1016/j.gofs.2018.12.011",

language = "English",

volume = "47",

pages = "111--119",

journal = "Gynecologie Obstetrique Fertilite et Senologie",

issn = "2468-7197",

number = "2",

}

Lavoué, V, Huchon, C, Akladios, C, Alfonsi, P, Bakrin, N, Ballester, M, Bendifallah, S, Bolze, PA, Bonnet, F, Bourgin, C, Chabbert-Buffet, N, Collinet, P, Courbiere, B, De la Motte Rouge, T, Devouassoux-Shisheboran, M, Falandry, C, Ferron, G, Fournier, L, Gladieff, L, Golfier, F, Gouy, S, Guyon, F, Lambaudie, E, Leary, A, Lécuru, F, Lefrère-Belda, MA, Leblanc, E, Lemoine, A, Narducci, F, Ouldamer, L, Pautier, P, Planchamp, F, Pouget, N, Ray-Coquard, I, Rousset-Jablonski, C, Sénéchal-Davin, C, Touboul, C, Thomassin-Naggara, I, Uzan, C, You, B & Daraï, E 2019, 'Part II drafted from the short text of the French guidelines entitled “Initial management of patients with epithelial ovarian cancer” developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment, elderly, fertility preservation, follow-up)', Gynecologie Obstetrique Fertilite et Senologie, VOL. 47, Numéro 2, p. 111-119. https://doi.org/10.1016/j.gofs.2018.12.011

Part II drafted from the short text of the French guidelines entitled “Initial management of patients with epithelial ovarian cancer” developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment, elderly, fertility preservation, follow-up). / Lavoué, V.; Huchon, C.; Akladios, C. et al.
Dans: Gynecologie Obstetrique Fertilite et Senologie, Vol 47, Numéro 2, 01.02.2019, p. 111-119.

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

TY - JOUR

T1 - Part II drafted from the short text of the French guidelines entitled “Initial management of patients with epithelial ovarian cancer” developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment, elderly, fertility preservation, follow-up)

AU - Lavoué, V.

AU - Huchon, C.

AU - Akladios, C.

AU - Alfonsi, P.

AU - Bakrin, N.

AU - Ballester, M.

AU - Bendifallah, S.

AU - Bolze, P. A.

AU - Bonnet, F.

AU - Bourgin, C.

AU - Chabbert-Buffet, N.

AU - Collinet, P.

AU - Courbiere, B.

AU - De la Motte Rouge, T.

AU - Devouassoux-Shisheboran, M.

AU - Falandry, C.

AU - Ferron, G.

AU - Fournier, L.

AU - Gladieff, L.

AU - Golfier, F.

AU - Gouy, S.

AU - Guyon, F.

AU - Lambaudie, E.

AU - Leary, A.

AU - Lécuru, F.

AU - Lefrère-Belda, M. A.

AU - Leblanc, E.

AU - Lemoine, A.

AU - Narducci, F.

AU - Ouldamer, L.

AU - Pautier, P.

AU - Planchamp, F.

AU - Pouget, N.

AU - Ray-Coquard, I.

AU - Rousset-Jablonski, C.

AU - Sénéchal-Davin, C.

AU - Touboul, C.

AU - Thomassin-Naggara, I.

AU - Uzan, C.

AU - You, B.

AU - Daraï, E.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Adjuvant chemotherapy with carboplatin and paclitaxel is recommended for all high-grade ovarian or Fallopian tube cancers, stage FIGO I-IIA (grade A). After a complete first surgery, it is recommended to deliver 6 cycles of intravenous (grade A) or to propose intraperitoneal (grade B) chemotherapy, to be discussed with patient, according to the benefit/risk ratio. After a complete interval surgery for a FIGO III stage, the hyperthermic intra peritoneal chemotherapy (HIPEC) can be proposed in the same conditions of the OV-HIPEC trial (grade B). In case of tumor residue after surgery or FIGO stage IV, chemotherapy associated with bevacizumab is recommended (grade A). For BRCA mutated patient, Olaparib is recommended (grade B).

AB - Adjuvant chemotherapy with carboplatin and paclitaxel is recommended for all high-grade ovarian or Fallopian tube cancers, stage FIGO I-IIA (grade A). After a complete first surgery, it is recommended to deliver 6 cycles of intravenous (grade A) or to propose intraperitoneal (grade B) chemotherapy, to be discussed with patient, according to the benefit/risk ratio. After a complete interval surgery for a FIGO III stage, the hyperthermic intra peritoneal chemotherapy (HIPEC) can be proposed in the same conditions of the OV-HIPEC trial (grade B). In case of tumor residue after surgery or FIGO stage IV, chemotherapy associated with bevacizumab is recommended (grade A). For BRCA mutated patient, Olaparib is recommended (grade B).

KW - Chemotherapy

KW - Fallopian tube cancer

KW - Guidelines

KW - Ovarian cancer

KW - Peritoneal cancer

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=85060548847&partnerID=8YFLogxK

U2 - 10.1016/j.gofs.2018.12.011

DO - 10.1016/j.gofs.2018.12.011

M3 - Article

C2 - 30704955

AN - SCOPUS:85060548847

SN - 2468-7197

VL - 47

SP - 111

EP - 119

JO - Gynecologie Obstetrique Fertilite et Senologie

JF - Gynecologie Obstetrique Fertilite et Senologie

IS - 2

ER -

Lavoué V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M et al. Part II drafted from the short text of the French guidelines entitled “Initial management of patients with epithelial ovarian cancer” developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment, elderly, fertility preservation, follow-up). Gynecologie Obstetrique Fertilite et Senologie. 2019 févr. 1;47(2):111-119. doi: 10.1016/j.gofs.2018.12.011